Westover Capital Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.69M | Hold |
3,189
| – | – | 0.28% | 72 |
|
|
2026
Q1 | $1.53M | Sell |
3,189
-4
| -0.1% | -$2.05K | 0.28% | 72 |
|
|
2025
Q4 | $1.79M | Sell |
3,193
-21
| -0.7% | -$11.9K | 0.33% | 64 |
|
|
2025
Q3 | $1.65M | Sell |
3,214
-36
| -1% | -$15.7K | 0.31% | 67 |
|
|
2025
Q2 | $1.02M | Sell |
3,250
-1,771
| -35% | -$532K | 0.2% | 97 |
|
|
2025
Q1 | $1.53M | Sell |
5,021
-73
| -1% | -$24.6K | 0.34% | 67 |
|
|
2024
Q4 | $1.69M | Sell |
5,094
-356
| -7% | -$121K | 0.37% | 61 |
|
|
2024
Q3 | $1.82M | Buy |
5,450
+236
| +5% | +$89.7K | 0.35% | 62 |
|
|
2024
Q2 | $2.15M | Buy |
5,214
+172
| +3% | +$68.1K | 0.55% | 48 |
|
|
2024
Q1 | $2.04M | Buy |
5,042
+76
| +2% | +$26.7K | 0.6% | 49 |
|
|
2023
Q4 | $1.52M | Buy |
4,966
+726
| +17% | +$196K | 0.5% | 52 |
|
|
2023
Q3 | $1.03M | Sell |
4,240
-255
| -6% | -$65.2K | 0.37% | 66 |
|
|
2023
Q2 | $1.08M | Buy |
4,495
+1,250
| +39% | +$260K | 0.38% | 65 |
|
|
2023
Q1 | $610K | Sell |
3,245
-4
| -0.1% | -$827 | 0.23% | 86 |
|
|
2022
Q4 | $690K | Sell |
3,249
-3,867
| -54% | -$773K | 0.27% | 79 |
|
|
2022
Q3 | $1.12M | Sell |
7,116
-134
| -2% | -$21.4K | 0.43% | 64 |
|
|
2022
Q2 | $1.08M | Sell |
7,250
-258
| -3% | -$37.3K | 0.4% | 62 |
|
|
2022
Q1 | $1.23M | Sell |
7,508
-686
| -8% | -$113K | 0.38% | 63 |
|
|
2021
Q4 | $1.78M | Sell |
8,194
-980
| -11% | -$205K | 0.52% | 58 |
|
|
2021
Q3 | $1.74M | Sell |
9,174
-21
| -0.2% | -$3.83K | 0.54% | 55 |
|
|
2021
Q2 | $1.62M | Sell |
9,195
-627
| -6% | -$108K | 0.52% | 56 |
|
|
2021
Q1 | $1.61M | Sell |
9,822
-803
| -8% | -$123K | 0.55% | 54 |
|
|
2020
Q4 | $1.48M | Sell |
10,625
-210
| -2% | -$26.5K | 0.53% | 56 |
|
|
2020
Q3 | $1.21M | Sell |
10,835
-2,548
| -19% | -$295K | 0.5% | 54 |
|
|
2020
Q2 | $1.25M | Sell |
13,383
-2,884
| -18% | -$245K | 0.58% | 51 |
|
|
2020
Q1 | $1.19M | Buy |
16,267
+285
| +2% | +$24.7K | 0.65% | 47 |
|
|
2019
Q4 | $1.34M | Sell |
15,982
-452
| -3% | -$35K | 0.6% | 48 |
|
|
2019
Q3 | $1.38M | Sell |
16,434
-1,959
| -11% | -$148K | 0.65% | 44 |
|
|
2019
Q2 | $1.2M | Sell |
18,393
-938
| -5% | -$54.1K | 0.59% | 47 |
|
|
2019
Q1 | $1.14M | Buy |
19,331
+1,304
| +7% | +$77.9K | 0.59% | 49 |
|
|
2018
Q4 | $954K | Buy |
+18,027
| New | +$990K | 0.6% | 52 |
|
Other funds holding MEDP
WA
Westover Capital Advisors's MEDP Position: Q2 2026 in Review
Westover Capital Advisors held its Medpace (MEDP) position steady in Q2 2026 at 3,189 shares worth $1.69M. The position accounts for 0.28% of the portfolio, ranked #72.
Westover Capital Advisors first reported a position in MEDP in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.15M in Q2 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Westover Capital Advisors held 3,189 shares of Medpace worth $1.69M as of Q2 2026.
- Westover Capital Advisors left its Medpace share count unchanged in Q2 2026.
- Medpace made up 0.28% of Westover Capital Advisors's portfolio in Q2 2026, its #72 holding.
- Westover Capital Advisors first reported a position in Medpace in Q4 2018 and has held it in 31 quarters since.
- Westover Capital Advisors's Medpace position peaked at $2.15M in Q2 2024.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Westover Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.